Combination therapy trial of panitumumab(Pmab) with FOLFIRI for inoperable advanced recurrent colorectal cancer first-line chemotherapy
收藏NIAID Data Ecosystem2026-03-07 收录
下载链接：
https://www.omicsdi.org/dataset/ecrin-mdr-crc/2620635
下载链接
链接失效反馈官方服务：
资源简介：
Interventions: FOLFIRI:irinotecan 150mg/m2, l-LV 200mg/m2 5FU400mg/m2(bolus), 2400mg/m2(infusional) Panitumumab:6mg/kg to be repeated every 2 weeks until meeting the withdrawal criteria.
Primary outcome(s): Overall response rate
Study Design: Single arm Non-randomized
创建时间：
2011-04-15
